Pygeum Africanum for Urinary Tract Health

Research suggests that Pygeum africanum bark extract may improve urinary tract symptoms associated with benign prostatic hyperplasia (BPH), including reduced nighttime urination and improved urine flow, based on a moderately large body of evidence that includes multiple systematic reviews, meta-analyses, and randomized controlled trials. A notable 2000 meta-analysis of 18 RCTs found moderately large improvements in urologic symptoms compared to placebo, and several subsequent systematic and narrative reviews have broadly reinforced these findings, consistently characterizing the evidence as supportive of modest clinical benefit for mild-to-moderate BPH-related symptoms. Studies indicate the effect is generally attributed to mechanisms involving prostate cell proliferation, growth factor interference, and bladder function, though the underlying pharmacology is still being characterized. That said, some broader comparative analyses have noted that the evidence base for Pygeum africanum is less robust than that for other plant-based options such as saw palmetto, with limitations including short trial durations, variable reporting quality, and a general call across multiple reviews for larger, longer, and more rigorously designed trials before firm clinical recommendations can be made.